Open access · CC-BY
via OpenAlex
Skeletal Senescence with Aging and Type 2 Diabetes
Endocrinology and Metabolism · 2023 · ▲ 12 citations
Abstract
Osteoporosis and type 2 diabetes (T2D) are common diseases that often coexist. While both of these diseases are associated with poor bone quality and increased fracture risk, their pathogenesis of increased fracture risk differs and is multifactorial. Mounting evidence now indicates that key fundamental mechanisms that are central to both aging and energy metabolism exist. Importantly, these mechanisms represent potentially modifiable therapeutic targets for interventions that could prevent or alleviate multiple complications of osteoporosis and T2D, including poor bone quality. One such mechanism that has gained increasing momentum is senescence(definition), which is a cell fate that contributes to multiple chronic diseases. Accumulating evidence has established that numerous boneresident cell types become susceptible to cellular senescence with old age. Recent work also demonstrates that T2D causes the premature accumulation of senescent osteocytes during young adulthood, at least in mice, although it remains to be seen which other bone-resident cell types become senescent with T2D. Given that therapeutically removing senescent cells can alleviate age-related bone loss and T2D-induced metabolic dysfunction, it will be important in future studies to rigorously test whether interventions that eliminate senescent cells can also alleviate skeletal dysfunction in context of T2D, as it does with aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3803/enm.2023.1727
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Farr, J.N. (2023). Skeletal Senescence with Aging and Type 2 Diabetes. <em>Endocrinology and Metabolism</em>. https://doi.org/10.3803/enm.2023.1727
Vancouver
Farr JN. Skeletal Senescence with Aging and Type 2 Diabetes. Endocrinology and Metabolism. 2023. doi:10.3803/enm.2023.1727.
BibTeX
@article{joshua2023Skelet,
title = {Skeletal Senescence with Aging and Type 2 Diabetes},
author = {Joshua N. Farr},
journal = {Endocrinology and Metabolism},
year = {2023},
doi = {10.3803/enm.2023.1727},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Gerontologist 2016
Citation only
INTERVENTIONS TARGETING CELLULAR SENESCENCE: THE PATH TO TRANSLATION
EBioMedicine 2017
Open access · CC-BY
Cellular Senescence: A Translational Perspective
Bone Research 2025
Open access · CC-BY
Cellular senescence and other age-related mechanisms in skeletal diseases
European Journal of Neuroscience 2011
Citation only
Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype
Endocrinology 2021
Open access · CC-BY
Senolytics: Potential for Alleviating Diabetes and Its Complications
Journal of Clinical Investigation 2022
Open access · CC-BY